ESR1 and breast carcinoma: The expression of GATA3 is strongly associated with estrogen receptor (ER) expression in breast cancer (11) and there is accumulating evidence that GATA3 may be used as a clinical marker to determine response to hormonal therapy and refine the prognosis of breast cancer patients (12,13).